ENDPOINTS NEWS3h
Flori­da car deal­er joins in­sulin pric­ing fight against Eli Lil­ly, Sanofi
A Florida-based car dealer has joined mounting litigation against Eli Lilly, Novo Nordisk and Sanofi over what it calls the ...
ENDPOINTS NEWS4h
Eli Lil­ly seeks to join law­suit over end of tirzepatide short­age
Eli Lilly has asked to intervene in litigation between a compounding pharmacy trade group and the FDA over the agency’s ...
ENDPOINTS NEWS4h
No­vo pe­ti­tions FDA over Vic­toza com­pound­ing as first gener­ic wins ap­proval
Novo Nordisk is continuing its citizen petition crusade at the FDA, this time aiming to stop the compounding of Victoza, its ...
ENDPOINTS NEWS8h
GSK’s Nu­cala bags an­oth­er Chi­na ap­proval, but biggest test yet to come
GSK's Nucala gets China approval for chronic rhinosinusitis with nasal polyps; awaits FDA decision for COPD in May as it ...
ENDPOINTS NEWS8h
Af­ter Ca­griSe­ma, eyes are on Lil­ly’s oral GLP-1 as next key obe­si­ty play
Anticipation builds for Eli Lilly's oral obesity drug orforglipron's trial results in 2025, following Novo Nordisk's ...